Revascularization reduces mortality in patients with high risk coronary artery disease based on multi-slice CT

Original title: All-cause mortality benefit of coronary revascularization vs. medical therapy in patients without known coronary artery disease undergoing coronary computed tomographic angiography: results from CONFIRM (Coronary CT Angiography EvaluatioN For Clinical Outcomes: An InteRnational Multicenter Registry) Reference: James K Min et al. European Heart Journal (2012) 33, 3088–3097 doi:10.1093/eurheartj/ehs315.

Several large studies have shown revascularization reduces mortality in stable patients with high risk CAD based on conventional angiography. The goal of this study was to determine the impact in mortality rate of revascularization vs. medical therapy of patients with coronary disease based on CT. 

This observational study included 15223 patients without known coronary condition undergoing multi-slice coronary CT (≥ 64 detectors), divided in high risk (two-vessel CAD with proximal left anterior descending artery involvement, three-vessel CAD, and left main CAD) and low risk CAD. To identify revascularization or medical therapy predictors, they created a score developed by logistic regression. The primary end point was all-cause mortality. 

Revascularization rate was different depending on severity, from 3.8% for non-high-risk CAD to 51.2% high-risk CAD (p<0.01). 82.8% of revascularized patients were treated with angioplasty. Follow up median was 2.1 years (interquartile range 1.4-3.3 years).

After adjusting confounding factors, a reduction in all-cause mortality rates was observed in revascularized patients with high risk CAD, compared to those that received medical therapy (2.28% vs. 5.34% respectively p=0.0075). In low risk CAD patients no differences were observed (2.06% vs. 0.97% p=0.138).

Conclusion 

In patients with no previous history of CAD classified as high risk CAD patients based on multi-slice CT, revascularization reduced all-cause mortality rate.

Editorial Comment:

As an observation study, all outcomes produce more hypotheses that require further randomized studies. On the other hand, CTs are competing with functional studies as screening techniques and this study provides us with the tools to decide when to proceed with coronary angiography and revascularization.

SOLACI.ORG

More articles by this author

COILSEAL: Use of Coils in Percutaneous Coronary Intervention, Useful for Complication Management?

The use of coils as vascular closing tool has been steadily expanding beyond its traditional role in neuroradiology into coronary territory, where it remains...

Treatment of In-Stent Restenosis in Small Vessels with Paclitaxel-Coated Balloons

Coronary artery disease (CAD) in smaller epicardial vessels occurs in 30% to 67% of patients undergoing percutaneous coronary intervention and poses particular technical challenges....

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Coronary perforations remain one of the most serious complications of percutaneous coronary intervention (PCI), especially in cases of Ellis ruptures type III. In these...

Left Main Coronary Artery Disease: Intravascular Imaging-Guided PCI vs. Coronary Artery Bypass Grafting

Multiple randomized clinical trials have demonstrated superior outcomes with coronary artery bypass grafting (CABG) vs. percutaneous coronary intervention (PCI) in patients with left main...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

COILSEAL: Use of Coils in Percutaneous Coronary Intervention, Useful for Complication Management?

The use of coils as vascular closing tool has been steadily expanding beyond its traditional role in neuroradiology into coronary territory, where it remains...

Treatment of In-Stent Restenosis in Small Vessels with Paclitaxel-Coated Balloons

Coronary artery disease (CAD) in smaller epicardial vessels occurs in 30% to 67% of patients undergoing percutaneous coronary intervention and poses particular technical challenges....

Contemporary Challenges in Left Atrial Appendage Closure: Updated Approach to Device Embolization

Even though percutaneous left atrial appendage (LAA) closure is generally safe, device embolization – with 0 to 1.5% global incidence – is still a...